# Healthstream Inc: overview

HSTM · Nasdaq · CIK 1095565 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hstm.md) · [Financials](/companies/hstm/financials.md) · [Filings](/companies/hstm/filings.md) · [Insiders](/companies/hstm/insiders.md)

Latest reported revenue: [$83.7m](/filings/0001437749-26-026301.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001437749-26-026301).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [73.1](/filings/0001437749-25-033632.md) | [74.2 d](/filings/0001437749-26-005916.md) | [73.5](/filings/0001437749-26-015213.md) | [74.4](/filings/0001437749-26-026301.md) | [76.5](/filings/0001437749-25-033632.md) | [79.7 d](/filings/0001437749-26-005916.md) | [81.2](/filings/0001437749-26-015213.md) | [83.7](/filings/0001437749-26-026301.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [8.9%](/filings/0001437749-25-033632.md) | [6.3% d](/filings/0001437749-26-005916.md) | [6.0%](/filings/0001437749-26-015213.md) | [7.9%](/filings/0001437749-26-026301.md) | [9.9%](/filings/0001437749-25-033632.md) | [3.0% d](/filings/0001437749-26-005916.md) | [9.3%](/filings/0001437749-26-015213.md) | [9.9%](/filings/0001437749-26-026301.md) |
| Net margin | % | [7.8%](/filings/0001437749-25-033632.md) | [6.6% d](/filings/0001437749-26-005916.md) | [5.9%](/filings/0001437749-26-026301.md) | [7.2%](/filings/0001437749-26-026301.md) | [8.0%](/filings/0001437749-25-033632.md) | [3.2% d](/filings/0001437749-26-005916.md) | [7.3%](/filings/0001437749-26-026301.md) | [8.0%](/filings/0001437749-26-026301.md) |
| Diluted EPS | $ per share | [0.19](/filings/0001437749-25-033632.md) | not reported | [0.14](/filings/0001437749-26-015213.md) | [0.18](/filings/0001437749-26-026301.md) | [0.20](/filings/0001437749-25-033632.md) | not reported | [0.20](/filings/0001437749-26-015213.md) | [0.23](/filings/0001437749-26-026301.md) |
| Free cash flow | $m | [18.8 d](/filings/0001437749-25-033632.md) | [11.0 d](/filings/0001437749-26-005916.md) | [26.0](/filings/0001437749-26-015213.md) | [2.7 d](/filings/0001437749-26-026301.md) | [17.9 d](/filings/0001437749-25-033632.md) | [13.0 d](/filings/0001437749-26-005916.md) | [26.4](/filings/0001437749-26-015213.md) | [12.5 d](/filings/0001437749-26-026301.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [257](/filings/0001437749-24-005530.md) | [267](/filings/0001437749-25-005705.md) | [279](/filings/0001437749-26-005916.md) | [292](/filings/0001437749-26-005916.md) | [304](/filings/0001437749-26-005916.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [3.1%](/filings/0001437749-24-005530.md) | [4.7%](/filings/0001437749-25-005705.md) | [5.7%](/filings/0001437749-26-005916.md) | [7.3%](/filings/0001437749-26-005916.md) | [6.7%](/filings/0001437749-26-005916.md) |
| Net margin | % | [2.3%](/filings/0001437749-24-005530.md) | [4.5%](/filings/0001437749-25-005705.md) | [5.5%](/filings/0001437749-26-005916.md) | [6.9%](/filings/0001437749-26-005916.md) | [6.0%](/filings/0001437749-26-005916.md) |
| Diluted EPS | $ per share | [0.18](/filings/0001437749-24-005530.md) | [0.39](/filings/0001437749-25-005705.md) | [0.50](/filings/0001437749-26-005916.md) | [0.66](/filings/0001437749-26-005916.md) | [0.61](/filings/0001437749-26-005916.md) |
| Free cash flow | $m | [39.0](/filings/0001437749-24-005530.md) | [49.4](/filings/0001437749-25-005705.md) | [61.8](/filings/0001437749-26-005916.md) | [56.3](/filings/0001437749-26-005916.md) | [59.6](/filings/0001437749-26-005916.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hstm/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-23 | [Rebrovick Linda](/insiders/1217283.md) | Director | Sale (S) | 12,000 | $35.00 | $420.0k | [Form 4](/filings/0001437749-26-033424.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $111.2m | 4,080,144 |  | Added +228,215 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $42.5m | 1,557,981 |  | Added +101,938 |
| [Copeland Capital Management, LLC](/funds/1541743.md) | 2026-06-30 | $34.0m | 1,248,384 |  | Reduced −28,355 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $28.5m | 1,045,298 |  | Reduced −2,629 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $27.4m | 1,004,170 |  | Added +8,613 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $24.0m | 880,543 |  | Reduced −41,303 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $22.0m | 805,584 |  | Reduced −38,836 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $21.2m | 779,219 |  | Added +64,472 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $18.1m | 665,917 |  | Added +391,459 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $17.2m | 635,565 |  | Added +181,827 |

## Recent filings

[All 1,340 filings](/companies/hstm/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-23 | 16:15 ET | [8-K](/filings/0001437749-26-031062.md) | 5.02 Departure or appointment of officers or directors | 0001437749-26-031062 |
| 2026-09-21 | 16:55 ET | [SCHEDULE 13D](/filings/0002152025-26-000004.md) | Ownership report, active investor | 0002152025-26-000004 |
| 2026-09-15 | 09:27 ET | [8-K](/filings/0001437749-26-030399.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-030399 |
| 2026-09-14 | 09:21 ET | [8-K](/filings/0001437749-26-030240.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437749-26-030240 |
| 2026-08-06 | 16:31 ET | [10-Q](/filings/0001437749-26-026301.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026301 |
| 2026-08-03 | 16:34 ET | [8-K](/filings/0001437749-26-025455.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-025455 |
| 2026-07-29 | 16:30 ET | [8-K](/filings/0001437749-26-024890.md) | 8.01 Other events | 0001437749-26-024890 |
| 2026-05-29 | 16:34 ET | [8-K](/filings/0001437749-26-018888.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-018888 |
| 2026-05-08 | 17:19 ET | [8-K](/filings/0001437749-26-015956.md) | 5.02 Departure or appointment of officers or directors | 0001437749-26-015956 |
| 2026-05-06 | 16:32 ET | [10-Q](/filings/0001437749-26-015213.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015213 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-005916.md), filed Feb 27, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/993a3eec-aa86-4d78-a4a1-c1bd751610bb)

## About the filer

- CIK: 1095565
- Tickers: HSTM
- Exchange: Nasdaq
- SIC code: 7370 Services-Computer Programming, Data Processing, Etc.
- State of incorporation: TN
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 20:12 ET. No prices; not investment advice.